| Analysis | Metabolite Name | Measured Value | Units | Model | Intervention |
|---|---|---|---|---|---|
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.0054 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.0070 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.011 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.012 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.014 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.015 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.018 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.019 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.023 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.025 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.027 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.028 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.030 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.031 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | 2-Oxoglutaric acid | 0.032 | peak area | Wild type | B. breve MCC1274 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|